To include your compound in the COVID-19 Resource Center, submit it here.

Takeda pharmaceuticals news

Takeda announced the reorganization of its commercial and R&D operations -- its first major organizational move since naming Christophe Weber as COO, effective last April, and president, effective last June.Takeda said the reorganization is designed to strengthen communication between its commercial and R&D divisions.

Takeda's commercial division will establish five regional

Read the full 511 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE